KK
BEAM icon

KLP Kapitalforvaltning’s Beam Therapeutics BEAM Stock Holding History

KLP Kapitalforvaltning’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$690K Hold
20,100
– – ﹤0.01% 1345
2026
Q1 		$479K Buy
20,100
+800
+4% +$22.2K ﹤0.01% 1444
2025
Q4 		$535K Buy
19,300
+1,800
+10% +$45.9K ﹤0.01% 1382
2025
Q3 		$425K Hold
17,500
– – ﹤0.01% 1478
2025
Q2 		$298K Sell
17,500
-2,000
-10% -$34.8K ﹤0.01% 1604
2025
Q1 		$381K Buy
19,500
+6,100
+46% +$160K ﹤0.01% 1448
2024
Q4 		$332K Buy
+13,400
New +$342K ﹤0.01% 1590

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

KLP Kapitalforvaltning's BEAM Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 20,100 shares worth $690K. The position accounts for ﹤0.01% of the portfolio, ranked #1345.

KLP Kapitalforvaltning first reported a position in BEAM in Q4 2024 and has held it in 7 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • KLP Kapitalforvaltning held 20,100 shares of Beam Therapeutics worth $690K as of Q2 2026.
  • KLP Kapitalforvaltning left its Beam Therapeutics share count unchanged in Q2 2026.
  • Beam Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1345 holding.
  • KLP Kapitalforvaltning first reported a position in Beam Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.